Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Schreier

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|October 8, 2013
[A history and review of cholesterol ester transfer protein inhibitors and their contribution to the understanding of the physiology and pathophysiology of high density lipoprotein]Pablo Corral, Laura Schreier
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 28, 2011
Metalloproteinases in metabolic syndromeGabriela Berg, Veronica Miksztowicz, Laura Schreier
Hormone Molecular Biology and Clinical Investigation|November 6, 2014
Circulating and adipose tissue matrix metalloproteinases in cardiometabolic risk environments: pathophysiological aspectsGabriela Berg, Laura Schreier, Veronica Miksztowicz
Current Opinion in Endocrinology, Diabetes, and Obesity|December 17, 2025
Inhibition of angiopoietin-like protein 3 as a target for managing hypertriglyceridemiaPablo Corral, Natalia Nardelli, Laura Schreier
Current Opinion in Lipidology|May 16, 2025
Are Lipoprotein(a) levels decreased in insulin resistance and type 2 diabetes?Pablo Corral, María Gabriela Matta, Laura Schreier
Hormone Molecular Biology and Clinical Investigation|September 2, 2018
Metalloproteinases in non-alcoholic fatty liver disease and their behavior in liver fibrosisMagalí Barchuk, Laura Schreier, Gabriela Berg, et al.
Investigacion Clinica|September 7, 2010
[APOE-219g/T polymorphism related to serum lipid levels in atherosclerotic patients from Argentina]Virginia Bañres, Diego Wyszynski, Laura Schreier, et al.
Gaceta Medica De Mexico|January 20, 2025
Application of the 6-SNP elevated LDL-cholesterol polygenic risk score in individuals with familial hypercholesterolemia phenotype from an Argentine populationVirginia Bañares, Javier Martini, Graciela López, et al.
Microvascular Research|June 20, 2013
Role of HDL in neutralizing the VLDL effect on endothelial dysfunctionValeria Zago, Susana Gorzalczany, Diego Lucero, et al.
Current Diabetes Reports|January 6, 2025
Impact of SGLT2 Inhibitors on Lipoproteins in Type 2 DiabetesPablo Corral, Natalia Nardelli, Alicia Elbert, et al.
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|October 8, 2013
[A history and review of cholesterol ester transfer protein inhibitors and their contribution to the understanding of the physiology and pathophysiology of high density lipoprotein]Pablo Corral, Laura Schreier
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 28, 2011
Metalloproteinases in metabolic syndromeGabriela Berg, Veronica Miksztowicz, Laura Schreier
Hormone Molecular Biology and Clinical Investigation|November 6, 2014
Circulating and adipose tissue matrix metalloproteinases in cardiometabolic risk environments: pathophysiological aspectsGabriela Berg, Laura Schreier, Veronica Miksztowicz
Current Opinion in Endocrinology, Diabetes, and Obesity|December 17, 2025
Inhibition of angiopoietin-like protein 3 as a target for managing hypertriglyceridemiaPablo Corral, Natalia Nardelli, Laura Schreier
Current Opinion in Lipidology|May 16, 2025
Are Lipoprotein(a) levels decreased in insulin resistance and type 2 diabetes?Pablo Corral, María Gabriela Matta, Laura Schreier
Hormone Molecular Biology and Clinical Investigation|September 2, 2018
Metalloproteinases in non-alcoholic fatty liver disease and their behavior in liver fibrosisMagalí Barchuk, Laura Schreier, Gabriela Berg, et al.
Investigacion Clinica|September 7, 2010
[APOE-219g/T polymorphism related to serum lipid levels in atherosclerotic patients from Argentina]Virginia Bañres, Diego Wyszynski, Laura Schreier, et al.
Gaceta Medica De Mexico|January 20, 2025
Application of the 6-SNP elevated LDL-cholesterol polygenic risk score in individuals with familial hypercholesterolemia phenotype from an Argentine populationVirginia Bañares, Javier Martini, Graciela López, et al.
Microvascular Research|June 20, 2013
Role of HDL in neutralizing the VLDL effect on endothelial dysfunctionValeria Zago, Susana Gorzalczany, Diego Lucero, et al.
Current Diabetes Reports|January 6, 2025
Impact of SGLT2 Inhibitors on Lipoproteins in Type 2 DiabetesPablo Corral, Natalia Nardelli, Alicia Elbert, et al.
Pageof 8